| Title : Beta-caryophyllene, a CB2R selective agonist, protects against cognitive impairment caused by neuro-inflammation and not in dementia due to ageing induced by mitochondrial dysfunction - Kanojia_2021_CNS.Neurol.Disord.Drug.Targets__ |
| Author(s) : Kanojia U , Chaturbhuj SG , Sankhe R , Das M , Surubhotla R , Krishnadas N , Gourishetti K , Nayak PG , Kishore A |
| Ref : CNS Neurol Disord Drug Targets , : , 2021 |
| Abstract : Kanojia_2021_CNS.Neurol.Disord.Drug.Targets__ |
| ESTHER : Kanojia_2021_CNS.Neurol.Disord.Drug.Targets__ |
| PubMedSearch : Kanojia_2021_CNS.Neurol.Disord.Drug.Targets__ |
| PubMedID: 33530917 |
Kanojia U, Chaturbhuj SG, Sankhe R, Das M, Surubhotla R, Krishnadas N, Gourishetti K, Nayak PG, Kishore A (2021)
Beta-caryophyllene, a CB2R selective agonist, protects against cognitive impairment caused by neuro-inflammation and not in dementia due to ageing induced by mitochondrial dysfunction
CNS Neurol Disord Drug Targets
:
Kanojia U, Chaturbhuj SG, Sankhe R, Das M, Surubhotla R, Krishnadas N, Gourishetti K, Nayak PG, Kishore A (2021)
CNS Neurol Disord Drug Targets
: